Consumption of Coffee, Tea, and Caffeine at Midlife, and the Risk of Physical Frailty in Late Life
Overview
Affiliations
Objectives: Our study evaluated the prospective association between the consumption of caffeine-containing beverages at midlife and the risk of physical frailty at late life within a population-based cohort of Chinese adults living in Singapore over a follow-up period of 20 years.
Design: Prospective cohort study.
Setting And Participants: We used data from 12,583 participants from the baseline and third follow-up interviews of the Singapore Chinese Health Study (SCHS). Participants had a mean age of 53 years at baseline (1993-1998), and a mean age of 73 years during the third follow-up (2014-2017).
Methods: At baseline, habitual consumption of caffeine-containing beverages was evaluated using a validated semi-quantitative food-frequency questionnaire. During the third follow-up, physical frailty was assessed using the modified Cardiovascular Health Study phenotype.
Results: Compared with non-daily drinkers, those who drank 4 or more cups of coffee daily had reduced odds of physical frailty [odds ratio (OR), 0.54; 95% CI, 0.38-0.76]. Similarly, compared with those who hardly drank tea, participants who drank tea everyday also had reduced odds (OR, 0.82; 95% CI, 0.71-0.95). Total daily caffeine intake at midlife was associated with reduced likelihood of frailty at late life in a dose-response relationship (P < .001). Relative to their counterparts in the lowest quartile of daily caffeine intake (0-67.6 mg/d), participants in the highest quartile (223.0-910.4 mg/d) had an OR of 0.77 (95% CI, 0.66-0.91). Higher caffeine consumption was associated with lower likelihood of being in the slowest quintile for timed up-and-go (TUG) and weakest quintile for handgrip strength.
Conclusions And Implications: In this cohort of Chinese adults, higher consumption of caffeine at midlife, via coffee and tea, was associated with a reduced likelihood of physical frailty in late life.
Antonio J, Antonio B, Arent S, Candow D, Escalante G, Evans C Nutrients. 2025; 17(1.
PMID: 39796501 PMC: 11722573. DOI: 10.3390/nu17010067.
Shida T, Hatanaka S, Kojima N, Ohta T, Osuka Y, Maruo K Biogerontology. 2024; 26(1):21.
PMID: 39643817 DOI: 10.1007/s10522-024-10166-y.
Huang Y, Su H, Wang Y, Zhang Y Int Urol Nephrol. 2024; 56(12):3921-3932.
PMID: 39012583 DOI: 10.1007/s11255-024-04153-y.
Lai J, Chua K, Li H, Koh W Nutr J. 2024; 23(1):57.
PMID: 38835080 PMC: 11149349. DOI: 10.1186/s12937-024-00964-y.
Qian Z, Huang Y, Zhang Y, Yang N, Fang Z, Zhang C Front Genet. 2024; 15:1353908.
PMID: 38415056 PMC: 10897029. DOI: 10.3389/fgene.2024.1353908.